Healthcare Analytics, Population Health Management, Healthcare Big Data

Genomics

UMich, Apple Partner for Apple Watch Precision Medicine Study

March 25, 2019 - The University of Michigan (U-M) and Apple have launched a study that will combine the analysis of Apple Watch data with data from electronic health records (EHRs) and genomic testing to accelerate precision medicine research and gain insight into health, wellness, and disease. The three-year study, called Michigan Predictive Activity and Clinical Trajectories (MIPACT), has already...


More Articles

Geisinger, Intermountain Recognized for Precision Medicine Efforts

by Jessica Kent

Intermountain Healthcare and Geisinger Health System have each received recognition for their work in advancing precision medicine and improving patient care. At Geisinger, researchers will receive a $3.1 million NIH grant to further the...

Precision Medicine Partnership Aims to Curb Adverse Drug Events

by Jessica Kent

The University of Arizona (UA) College of Medicine - Phoenix and Banner Health have partnered to use precision medicine and clinical decision support to prevent adverse reactions to medications. The Flinn Foundation awarded a $1.5 million...

Genomic Sequencing Test Detects Lung Transplant Rejection

by Jessica Kent

A simple blood test that relies on genomic sequencing can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of rejection are evident. The test could enable physicians to intervene faster and...

NorthShore to Add Genomic Data to Primary Care for 10K Patients

by Jennifer Bresnick

Illinois-based NorthShore University HealthSystem is partnering with Color to bring genomic data into the decision-making process for primary care. The DNA10K initiative will engage more than 10,000 patients to integrate genomic testing...

23andMe, Lark Health Join Genetics, AI, Diabetes Prevention

by Jennifer Bresnick

Consumer genetic test company 23andMe has announced a partnership with Lark Health, provider of AI-driven health coaching programs, to allow consumers to use genetic test results to inform their approach to wellness. The...

Mount Sinai, Sanofi Partner on Precision Medicine for Asthma

by Jessica Kent

Mount Sinai Health System has launched a five-year, multisite study designed to advance precision medicine therapies for asthma patients. The collaborative effort, which includes Sema4 and Sanofi as partners, will follow nearly 1200 people...

FDA Recognizes Genomic Database to Advance Precision Medicine

by Jessica Kent

The FDA has formally recognized a public database containing genomic information, a significant step forward in driving the development of precision medicine and novel diagnostic technologies. The agency is recognizing the genetic variant...

Effective Precision Medicine Requires Moving Beyond the EHR

by Jennifer Bresnick

Electronic health records are not enough to support truly effective precision medicine at the point of care, said providers participating in a survey from KLAS research, but more targeted health IT tools are producing high rates of...

Consumers Curious About AI, Genetic Testing for Precision Medicine

by Jennifer Bresnick

Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos. The poll of more...

Machine Learning, Genomics Predict Risk of Aortic Aneurysm

by Jennifer Bresnick

The combination of machine learning tools and genomic data can help predict the risk of abdominal aortic aneurysm (AAA), one of the most frequently fatal heart conditions - and one that is most often diagnosed only after a patient’s...

Georgetown Offers Brain Cancer Data for Precision Medicine Research

by Jessica Kent

Georgetown Lombardi Comprehensive Cancer Center will now make its collection of brain cancer data freely available to precision medicine researchers worldwide. The dataset, called the REpository for Molecular BRAin Neoplasia DaTa...

Boston Children’s to Sequence DNA of 3000 Chronic Disease Patients

by Jessica Kent

Boston Children’s Hospital has announced that it will offer complete DNA sequencing to 3000 patients with epilepsy and inflammatory bowel disease in an effort to target treatments and accelerate medical research. The initiative will...

How to Bring Precision Medicine into Routine Clinical Care

by Jessica Kent

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

VA, IBM Watson Extend AI, Genomics Partnership for Cancer Care

by Jessica Kent

The Department of Veteran Affairs (VA) and IBM Watson Health have announced an extension of their partnership to bring artificial intelligence and genomic analytics to cancer care. The VA’s precision oncology program primarily...

Alabama Recruits for Statewide Population Health, Genomics Program

by Jessica Kent

The Alabama Genomic Health Initiative (AGHI) has begun recruiting participants for its population health program that will use genomic analysis to predict disease. AGHI is a collaborative effort between the University of Alabama at...

UPMC, UPitt Launch Genome Sequencing Center for Medical Research

by Jessica Kent

The University of Pittsburgh Medical Center (UPMC) and the University of Pittsburgh have announced the creation of the UPMC Genome Center, an advanced genome sequencing facility that will enhance clinical diagnostics and support precision...

NCI Studies Link Dozens of Genetic Variants to Cancer

by Jessica Kent

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

Clinical Decision Support from Dana-Farber Powers Cancer Care

by Jessica Kent

Experts at Dana-Farber Cancer Institute are partnering with Royal Philips to provide improved clinical decision support for cancer care. The incredibly complex nature of cancer, coupled with its many available treatment options, has long...

WVU Genetic Test to Improve Lung Cancer Treatment

by Jessica Kent

Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients will benefit from chemotherapy and...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy


no, thanks

Continue to site...